Versatility of Aminoglycosides and Prospects for Their Future
暂无分享,去创建一个
[1] C. Thompson,et al. Nucleotide sequence of a streptomycete aminoglycoside phosphotransferase gene and its relationship to phosphotransferases encoded by resistance plasmids. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Mazel,et al. Antibiotic Resistance in the ECOR Collection: Integrons and Identification of a Novel aad Gene , 2000, Antimicrobial Agents and Chemotherapy.
[3] P. Kuhnert,et al. Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. , 2001, Veterinary microbiology.
[4] F. Kayser,et al. Purification and characterization of an aminoglycoside inactivating enzyme from Staphylococcus epidermidis FK109 that nucleotidylates the 4'- and 4''-hydroxyl groups of the aminoglycoside antibiotics. , 1978, The Journal of antibiotics.
[5] C. A. Smith,et al. Characterization of transferable plasmids from Shigella flexneri 2a that confer resistance to trimethoprim, streptomycin, and sulfonamides. , 1986, Plasmid.
[6] E Westhof,et al. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. , 2001, Structure.
[7] E. Eber,et al. Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: A pilot study * , 2002, Pediatric pulmonology.
[8] C. Bertozzi,et al. Glycochemistry: Principles: Synthesis, and Applications , 2001 .
[9] R. Moellering. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options , 1991 .
[10] R. Hall,et al. New mobile gene cassettes containing an aminoglycoside resistance gene, aacA7, and a chloramphenicol resistance gene, catB3, in an integron in pBWH301 , 1995, Antimicrobial agents and chemotherapy.
[11] M. Inoue,et al. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. , 1994, Drugs under experimental and clinical research.
[12] S. Lory,et al. Complete genome sequence of Pseudomonas aeruginosa PAO 1 , an opportunistic pathogen , 2000 .
[13] T. Beveridge,et al. Gentamicin interaction with Pseudomonas aeruginosa cell envelope , 1986, Antimicrobial Agents and Chemotherapy.
[14] R. Jacobs,et al. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] D. Daigle,et al. Inhibition of Aminoglycoside Antibiotic Resistance Enzymes by Protein Kinase Inhibitors* , 1997, The Journal of Biological Chemistry.
[16] P. Visca,et al. Class 1 Integron-Borne Multiple-Antibiotic Resistance Carried by IncFI and IncL/M Plasmids in Salmonella enterica Serotype Typhimurium , 1998, Antimicrobial Agents and Chemotherapy.
[17] P. Fey,et al. Characterization of Plasmids Carrying CMY-2 from Expanded-Spectrum Cephalosporin-Resistant Salmonella Strains Isolated in the United States between 1996 and 1998 , 2002, Antimicrobial Agents and Chemotherapy.
[18] R. Schiffelers,et al. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies. , 2001, The Journal of antimicrobial chemotherapy.
[19] P. Courvalin,et al. Nucleotide sequence of Acinetobacter baumannii aphA‐6 gene: evolutionary and functional implications of sequence homologies with nucleotide‐binding proteins, kinases and other aminoglycoside‐modifying enzymes , 1988, Molecular microbiology.
[20] J. Puglisi,et al. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. , 1998, Journal of molecular biology.
[21] M. Pátek,et al. An integron of class 1 is present on the plasmid pCG4 from gram-positive bacterium Corynebacterium glutamicum. , 1998, FEMS microbiology letters.
[22] P. Rather,et al. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.
[23] P. Courvalin,et al. Characterization of the chromosomal aac(6')-Ij gene of Acinetobacter sp. 13 and the aac(6')-Ih plasmid gene of Acinetobacter baumannii , 1994, Antimicrobial Agents and Chemotherapy.
[24] B. Reiss,et al. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. , 1982, Gene.
[25] G. Archer,et al. The Staphylococci in Human Disease , 1996 .
[26] C. Wa,et al. Killing and regrowth of bacteria in vitro: a review. , 1990 .
[27] N. Cianciotto,et al. Isolation of a gene encoding a novel spectinomycin phosphotransferase from Legionella pneumophila , 1997, Antimicrobial agents and chemotherapy.
[28] R. Moellering. In Vitro Antibacterial Activity of the Aminoglycoside Antibiotics , 1983 .
[29] T. Imanaka,et al. Complete nucleotide sequences of Bacillus plasmids pUB110dB, pRBH1 and its copy mutants , 2004, Molecular and General Genetics MGG.
[30] S. Projan,et al. New (and not so new) antibacterial targets - from where and when will the novel drugs come? , 2002, Current opinion in pharmacology.
[31] R. Perry,et al. Yersinia pestis--etiologic agent of plague , 1997, Clinical microbiology reviews.
[32] V. Ramakrishnan,et al. Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit , 2001, Science.
[33] C. Kurland,et al. Codon‐specific missense errors in vivo. , 1983, The EMBO journal.
[34] R. Wagner,et al. E. coli ribosomes with a C912 to U base change in the 16S rRNA are streptomycin resistant. , 1986, The EMBO journal.
[36] J. Klastersky,et al. Susceptibility of "Pseudomonas aeruginosa" to combinations of antibiotics. , 1972, Pathologie-biologie.
[37] Ulrich Stelzl,et al. Protein synthesis at atomic resolution: mechanistics of translation in the light of highly resolved structures for the ribosome. , 2002, Current protein & peptide science.
[38] M. Barclay,et al. Once Daily Aminoglycoside Therapy , 1999, Clinical pharmacokinetics.
[39] G. Rossolini,et al. In70 of Plasmid pAX22, ablaVIM-1-Containing Integron Carrying a New Aminoglycoside Phosphotransferase Gene Cassette , 2001, Antimicrobial Agents and Chemotherapy.
[40] C. M. Collis,et al. Class 1 Integron Containing a New Gene Cassette, aadA10, Associated with Tn1404 from R151 , 2002, Antimicrobial Agents and Chemotherapy.
[41] P. Nordmann,et al. Molecular Characterization of a Novel Class 1 Integron Containing blaGES-1 and a Fused Product of aac(3)-Ib/aac(6")-Ib" Gene Cassettes in Pseudomonas aeruginosa , 2002, Antimicrobial Agents and Chemotherapy.
[42] S. Kocsi,et al. Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates , 1991, Antimicrobial Agents and Chemotherapy.
[43] D. Sherman,et al. Characterization of a Pseudomonas aeruginosa Efflux Pump Contributing to Aminoglycoside Impermeability , 1999, Antimicrobial Agents and Chemotherapy.
[44] P. Strike,et al. A pathway for the evolution of the plasmid NTP16 involving the novel kanamycin resistance transposon Tn4352. , 1987, Plasmid.
[45] A. Allsop. New antibiotic discovery, novel screens, novel targets and impact of microbial genomics. , 1998, Current opinion in microbiology.
[46] H. Chung,et al. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States , 1985, Antimicrobial Agents and Chemotherapy.
[47] Ronald N. Jones,et al. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] L. Kotra,et al. Aminoglycoside Antibiotics: Structures and Mechanisms of Action , 2001 .
[49] A. Tärnvik,et al. Susceptibility to beta-lactam antibiotics and gentamicin of gram-negative bacilli isolated from hospitalized patients: a Swedish multicenter study. , 1988, Scandinavian journal of infectious diseases.
[50] A. Osborn,et al. R391: a Conjugative Integrating Mosaic Comprised of Phage, Plasmid, and Transposon Elements , 2002, Journal of bacteriology.
[51] Michael H. Miller,et al. Gentamicin Uptake in Wild-Type and Aminoglycoside-Resistant Small-Colony Mutants of Staphylococcus aureus , 1980, Antimicrobial Agents and Chemotherapy.
[52] A. Berghuis,et al. Protein kinase inhibitors and antibiotic resistance. , 2002, Pharmacology & therapeutics.
[53] T Lambert,et al. A spontaneous point mutation in the aac(6')-Ib' gene results in altered substrate specificity of aminoglycoside 6'-N-acetyltransferase of a Pseudomonas fluorescens strain. , 1994, FEMS microbiology letters.
[54] A. Caprioli,et al. Detection and characterization of class 1 integrons in enterohemorrhagic Escherichia coli. , 2002, Microbial drug resistance.
[55] J. Duval,et al. Resistance of enterococci to aminoglycosides and glycopeptides. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[56] J. Kalinowski,et al. The 51,409-bp R-plasmid pTP10 from the multiresistant clinical isolate Corynebacterium striatum M82B is composed of DNA segments initially identified in soil bacteria and in plant, animal, and human pathogens , 2000, Molecular and General Genetics MGG.
[57] L. Brakier-Gingras,et al. Cross-linking of streptomycin to the 16S ribosomal RNA of Escherichia coli. , 1987, Biochemistry.
[58] R. Moellering,et al. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. , 1971, The Journal of clinical investigation.
[59] J. Ruiloba. [Antimicrobial combinations]. , 1972, Gaceta medica de Mexico.
[60] L. Dixon,et al. An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88. , 1994, Plasmid.
[61] Richard A. Moore,et al. Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei , 1999, Antimicrobial Agents and Chemotherapy.
[62] N. Legakis,et al. Survey of aminoglycoside resistance patterns. , 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.
[63] J. Karlowsky,et al. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. , 1994, The Journal of antimicrobial chemotherapy.
[64] P. Heinzel,et al. A second streptomycin resistance gene from Streptomyces griseus codes for streptomycin-3″-phosphotransferase , 1988, Archives of Microbiology.
[65] John W. Beaber,et al. Genomic and Functional Analyses of SXT, an Integrating Antibiotic Resistance Gene Transfer Element Derived from Vibrio cholerae , 2002, Journal of bacteriology.
[66] K. Shaw,et al. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups. , 1995, Journal of chemotherapy.
[67] P. Nordmann,et al. Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. , 1999, The Journal of antimicrobial chemotherapy.
[68] G. Eliopoulos,et al. Ribosomal Resistance of Clinical Enterococcal Isolates to Streptomycin , 1984, Antimicrobial Agents and Chemotherapy.
[69] W. S. Champney,et al. 30S Ribosomal Subunit Assembly Is a Target for Inhibition by Aminoglycosides in Escherichia coli , 2002, Antimicrobial Agents and Chemotherapy.
[70] European Study Group on Antibiotic Resistance. In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories , 2005, European Journal of Clinical Microbiology.
[71] Tetsuya Hayashi,et al. Complete Nucleotide Sequence of Plasmid Rts1: Implications for Evolution of Large Plasmid Genomes , 2002, Journal of bacteriology.
[72] Weber. Antimicrobial Therapy and Vaccines , 2002 .
[73] M. Raviglione,et al. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] D. Livermore,et al. In Vitro Activities of Antibiotics Alone and in Combination against Brucella melitensis at Neutral and Acidic pHs , 1999, Antimicrobial Agents and Chemotherapy.
[75] S. Magnet,et al. Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.
[76] P. Sparling,et al. Ribosomal Resistance to Streptomycin and Spectinomycin in Neisseria gonorrhoeae , 1974, Journal of bacteriology.
[77] Chantal D. Larose,et al. PCR mapping of integrons reveals several novel combinations of resistance genes , 1995, Antimicrobial agents and chemotherapy.
[78] B. D. Davis. Mechanism of bactericidal action of aminoglycosides , 1987, Microbiological reviews.
[79] P. Rather,et al. Activation of the 2′- N -Acetyltransferase Gene [aac(2′)-Ia] inProvidencia stuartii by an Interaction of AarP with the Promoter Region , 1999, Antimicrobial Agents and Chemotherapy.
[80] H. Sugisaki,et al. Nucleotide sequence of the kanamycin resistance transposon Tn903. , 1981, Journal of molecular biology.
[81] Arjun Srinivasan,et al. Vancomycin Resistance in Staphylococci , 2002, Clinical Microbiology Reviews.
[82] K. Bush,et al. How β-Lactamases Have Driven Pharmaceutical Drug Discovery , 1998 .
[83] G. Vovis,et al. Genomics and Antimicrobial Drug Discovery , 1999, Antimicrobial Agents and Chemotherapy.
[84] Overexpression and Characterization of the Chromosomal Aminoglycoside 2′-N-Acetyltransferase ofProvidencia stuartii , 2001, Antimicrobial Agents and Chemotherapy.
[85] M. Levison,et al. Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo , 1989, Antimicrobial Agents and Chemotherapy.
[86] S. Schwarz,et al. Nucleotide sequence and organization of plasmid pMVSCS1 from Mannheimia varigena: identification of a multiresistance gene cluster. , 2002, The Journal of antimicrobial chemotherapy.
[87] G. Drusano. Role of pharmacokinetics in the outcome of infections , 1988, Antimicrobial Agents and Chemotherapy.
[88] F. K. Gould,et al. Role of aminoglycosides in the treatment of bacterial endocarditis. , 2002, The Journal of antimicrobial chemotherapy.
[89] G. Sundin. Examination of base pair variants of the strA-strB streptomycin resistance genes from bacterial pathogens of humans, animals and plants. , 2000, The Journal of antimicrobial chemotherapy.
[90] F. Ratjen,et al. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis , 2001, The Lancet.
[91] H. Sørum,et al. Functional Tn5393-Like Transposon in the R Plasmid pRAS2 from the Fish Pathogen Aeromonas salmonicida subspecies salmonicida Isolated in Norway , 2000, Applied and Environmental Microbiology.
[92] D. Shlaes,et al. The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] J. Lemeland,et al. In Vitro Synergistic Effects of Double and Triple Combinations of β-Lactams, Vancomycin, and Netilmicin against Methicillin-Resistant Staphylococcus aureusStrains , 2000, Antimicrobial Agents and Chemotherapy.
[94] K. Shaw,et al. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. , 1995, Journal of chemotherapy.
[95] M. Sugiyama,et al. IS431mec-mediated integration of a bleomycin-resistance gene into the chromosome of a methicillin-resistant Staphylococcus aureus strain isolated in Japan , 1996, Applied Microbiology and Biotechnology.
[96] Ellen Murphy,et al. Genomics in anti-infective drug discovery--getting to endgame. , 2002, Current pharmaceutical design.
[97] H. Umezawa,et al. Syntheses of 6'-N-methyl-kanamycin and 3',4'-dideoxy-6'-N-methylkanamycin B active against resistant strains having 6'-N-acetylating enzymes. , 1972, The Journal of antibiotics.
[98] R. Allmansberger,et al. Genes for gentamicin-(3)-N-acetyl-transferases III and IV , 2004, Molecular and General Genetics MGG.
[99] K. E. Price,et al. Epidemiological studies of aminoglycoside resistance in the U.S.A. , 1981, The Journal of antimicrobial chemotherapy.
[100] A. Percival,et al. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. , 1967, Lancet.
[101] R. B. Henschke,et al. Nucleotide sequence analysis of 2″‐aminoglycoside nucleotidyl‐transferase ANT(2″) from Tn4000: its relationship with AAD(3″) and impact on Tn21 evolution , 1988, Molecular microbiology.
[102] D. Vapnek,et al. Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase. , 1985, Plasmid.
[103] T. Kato,et al. Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro. , 2000, The Journal of antimicrobial chemotherapy.
[104] E. Cundliffe. How antibiotic-producing organisms avoid suicide. , 1989, Annual review of microbiology.
[105] R. Moellering,et al. Antimicrobial-drug resistance. , 1996, The New England journal of medicine.
[106] A. Quittner,et al. Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection * † , 2002, Pediatric pulmonology.
[107] R. Hedges,et al. Resistance to apramycin in Escherichia coli isolated from animals: detection of a novel aminoglycoside-modifying enzyme. , 1984, Journal of general microbiology.
[108] S. Mobashery,et al. Resolving the antibiotic paradox: progress in understanding drug resistance and development of new antibiotics. , 1998 .
[109] F. Tenover,et al. Detection of a Streptomycin/Spectinomycin Adenylyltransferase Gene (aadA) in Enterococcus faecalis , 1999, Antimicrobial Agents and Chemotherapy.
[110] I. Chopra,et al. Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. , 1972, Journal of general microbiology.
[111] H. Sader,et al. In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals. , 2001, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[112] L. Kotra,et al. Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance , 2000, Antimicrobial Agents and Chemotherapy.
[113] J. Puglisi,et al. Structural origins of gentamicin antibiotic action , 1998, The EMBO journal.
[114] Neville Firth,et al. Complete Nucleotide Sequence of pSK41: Evolution of Staphylococcal Conjugative Multiresistance Plasmids , 1998, Journal of bacteriology.
[115] M. Delmée,et al. COMPARATIVE IN VITRO ACTIVITY OF ISEPAMICIN AND OTHER ANTIBIOTICS AGAINST GRAM-NEGATIVE BACILLI FROM INTENSIVE CARE UNITS (ICU) IN BELGIUM , 2001, Acta clinica Belgica.
[116] P. Rather,et al. Analysis of the aac(3)-VIa gene encoding a novel 3-N-acetyltransferase , 1993, Antimicrobial Agents and Chemotherapy.
[117] P. Gangadharam,et al. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes , 1995, Antimicrobial agents and chemotherapy.
[118] S. Mobashery,et al. Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[119] P. D. Cam,et al. Cholera in Vietnam: Changes in Genotypes and Emergence of Class I Integrons Containing Aminoglycoside Resistance Gene Cassettes in Vibrio cholerae O1 Strains Isolated from 1979 to 1996 , 1999, Journal of Clinical Microbiology.
[120] P. Rather,et al. The chromosomal 2'-N-acetyltransferase of Providencia stuartii: physiological functions and genetic regulation. , 1999, Frontiers in bioscience : a journal and virtual library.
[121] M. Ehrenberg,et al. Dissociation rates of peptidyl‐tRNA from the P‐site of E.coli ribosomes. , 1996, The EMBO journal.
[122] L. Ng,et al. Genetic characterization of kanamycin resistance in Campylobacter coli. , 1988, Annales de l'Institut Pasteur. Microbiology.
[123] F. Schluenzen,et al. Structure of Functionally Activated Small Ribosomal Subunit at 3.3 Å Resolution , 2000, Cell.
[124] Y. Nakamura,et al. Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. , 2000, Nucleic acids research.
[125] I. Phillips. AMINOGLYCOSIDES , 1982, The Lancet.
[126] A. Clarke,et al. The role of O-acetylation in the metabolism of peptidoglycan in Providencia stuartii. , 1996, Microbial drug resistance.
[127] G. Jacoby,et al. Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens , 1990, Antimicrobial Agents and Chemotherapy.
[128] M. Fling,et al. Nucleotide sequence of the transposon Tn7 gene encoding an aminoglycoside-modifying enzyme, 3"(9)-O-nucleotidyltransferase. , 1985, Nucleic acids research.
[129] E. Murphy. Nucleotide sequence of a spectinomycin adenyltransferase AAD(9) determinant from Staphylococcus aureus and its relationship to AAD(3″) (9) , 2004, Molecular and General Genetics MGG.
[130] M. Syvanen,et al. Evolved neomycin phosphotransferase from an isolate of Klebsiella pneumoniae , 1991, Molecular Microbiology.
[131] Robert M. Sweet,et al. Structure of an Enzyme Required for Aminoglycoside Antibiotic Resistance Reveals Homology to Eukaryotic Protein Kinases , 1997, Cell.
[132] V. Lorian. Antibiotics in laboratory medicine , 2005 .
[133] D. Hartung,et al. Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria , 1991, Infection.
[134] L. Young,et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[135] S. Signorelli. [Treatment of human brucellosis]. , 1951, Revista medica de Cordoba.
[136] S. Mobashery,et al. The use of neamine as a molecular template: inactivation of bacterial antibiotic resistance enzyme aminoglycoside 3'-phosphotransferase type IIa. , 1998, Bioorganic & medicinal chemistry letters.
[137] R. Venezia,et al. The resistance and integrase genes of pACM1, a conjugative multiple-resistance plasmid, from Klebsiella oxytoca. , 1997, Plasmid.
[138] Ronald N. Jones,et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[139] J. Staneck,et al. Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid , 1985, Antimicrobial Agents and Chemotherapy.
[140] J. Solera,et al. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[141] C. Herbert,et al. Sequence and interspecies transfer of an aminoglycoside phosphotransferase gene (APH) of Bacillus circulans. Self-defence mechanism in antibiotic-producing organisms. , 1986, The Biochemical journal.
[142] J. Duval,et al. Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium , 1993, Antimicrobial Agents and Chemotherapy.
[143] J. Shenep,et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. , 1991, The Journal of infectious diseases.
[144] J. Chow. Aminoglycoside resistance in enterococci. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[145] W. Craig,et al. Killing and regrowth of bacteria in vitro: a review. , 1990, Scandinavian journal of infectious diseases. Supplementum.
[146] E. J. Young,et al. An overview of human brucellosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[147] S. Calderwood,et al. Resistance to antibiotic synergism in Streptococcus faecalis: further studies with amikacin and with a new amikacin derivative, 4'-deoxy, 6'-N-methylamikacin , 1981, Antimicrobial Agents and Chemotherapy.
[148] L. Kotra,et al. From genes to sequences to antibiotics: prospects for future developments from microbial genomics. , 2000, Microbes and infection.
[149] P. Courvalin,et al. Characterization of Acinetobacter haemolyticus aac(6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin , 1993, Antimicrobial Agents and Chemotherapy.
[150] R. Moss. Administration of aerosolized antibiotics in cystic fibrosis patients. , 2001, Chest.
[151] L. E. Bryan,et al. Mechanism of Aminoglycoside Antibiotic Resistance in Anaerobic Bacteria: Clostridium perfringens and Bacteroides fragilis , 1979, Antimicrobial Agents and Chemotherapy.
[152] P. Courvalin,et al. Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities , 1986, Journal of bacteriology.
[153] Ronald N. Jones,et al. Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) , 1998, Antimicrobial Agents and Chemotherapy.
[154] A Yonath,et al. Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. , 2000, Cell.
[155] R. Mattaliano,et al. Nucleotide sequence of the hygromycin B phosphotransferase gene from Streptomyces hygroscopicus. , 1986, Nucleic acids research.
[156] Chi-Huey Wong,et al. Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes , 2000 .
[157] P. White,et al. Integrons and Gene Cassettes in theEnterobacteriaceae , 2001, Antimicrobial Agents and Chemotherapy.
[158] H. Nikaido,et al. Involvement of an Active Efflux System in the Natural Resistance of Pseudomonas aeruginosa to Aminoglycosides , 1999, Antimicrobial Agents and Chemotherapy.
[159] D. Leigh,et al. Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria. , 1981, The Journal of antimicrobial chemotherapy.
[160] D. Friend,et al. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages , 1992, Antimicrobial Agents and Chemotherapy.
[161] Teruyo Ito,et al. Cloning and Nucleotide Sequence Determination of the Entire mec DNA of Pre-Methicillin-Resistant Staphylococcus aureus N315 , 1999, Antimicrobial Agents and Chemotherapy.
[162] W. Fitzsimmons,et al. Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin , 1990, Antimicrobial Agents and Chemotherapy.
[163] L. Briceland,et al. Single Daily Dosing of Aminoglycosides , 1995, Pharmacotherapy.
[164] K. Shaw,et al. Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). , 1990, The Journal of antimicrobial chemotherapy.
[165] W. Craig,et al. Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design. , 1990, Infection control and hospital epidemiology.
[166] S. Gillespie,et al. Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective , 2002, Antimicrobial Agents and Chemotherapy.
[167] R. Woodgate,et al. Molecular Analysis of Antibiotic Resistance Gene Clusters in Vibrio cholerae O139 and O1 SXT Constins , 2001, Antimicrobial Agents and Chemotherapy.
[168] J. Davies,et al. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. , 1983, Gene.
[169] M. Zervos,et al. Detection of the High-Level Aminoglycoside Resistance Gene aph(2")-Ib in Enterococcus faecium , 2000, Antimicrobial Agents and Chemotherapy.
[170] H. Nikaido,et al. AcrD of Escherichia coli Is an Aminoglycoside Efflux Pump , 2000, Journal of bacteriology.
[171] E. J. Young,et al. Antimicrobial susceptibility of clinical isolates of Brucella. , 1986, Diagnostic microbiology and infectious disease.
[172] J. Spivey. The postantibiotic effect. , 1992, Clinical pharmacy.
[173] G. Wright,et al. Aminoglycoside antibiotics. Structures, functions, and resistance. , 1998, Advances in experimental medicine and biology.
[174] J. Davies,et al. Isolation and characterisation of an aminoglycoside phosphotransferase from neomycin-producing Micromonospora chalcea; comparison with that of Streptomyces fradiae and other producers of 4,6-disubstituted 2-deoxystreptamine antibiotics. , 1991, The Journal of antibiotics.
[175] A. Carattoli,et al. Antibiotic Resistance Conferred by a Conjugative Plasmid and a Class I Integron in Vibrio cholerae O1 El Tor Strains Isolated in Albania and Italy , 1999, Antimicrobial Agents and Chemotherapy.
[176] Sande Ma,et al. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. , 1976 .
[177] J. Hamilton-miller,et al. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus. , 1995, The Journal of antimicrobial chemotherapy.
[178] M. Ouellette,et al. Acquisition by a Campylobacter-like strain of aphA-1, a kanamycin resistance determinant from members of the family Enterobacteriaceae , 1987, Antimicrobial Agents and Chemotherapy.
[179] S. Carlson,et al. Relative Distribution and Conservation of Genes Encoding Aminoglycoside-Modifying Enzymes in Salmonella enterica Serotype Typhimurium Phage Type DT104 , 2001, Applied and Environmental Microbiology.
[180] A. Clarke,et al. Characterization of gentamicin 2'-N-acetyltransferase from Providencia stuartii: its use of peptidoglycan metabolites for acetylation of both aminoglycosides and peptidoglycan , 1997, Journal of bacteriology.
[181] G. Harding,et al. The Postantibiotic Effect: A Review of in Vitro and in Vivo Data , 1991, DICP : the annals of pharmacotherapy.
[182] Harry F. Noller,et al. Interaction of antibiotics with functional sites in 16S ribosomal RNA , 1987, Nature.
[183] P. McDonald,et al. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. , 1977, The Journal of infectious diseases.
[184] M. Zervos,et al. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus. , 2000, Diagnostic microbiology and infectious disease.
[185] P. O'Hara,et al. Development of a DNA probe from the deoxyribonucleotide sequence of a 3-N-aminoglycoside acetyltransferase [AAC(3)-I] resistance gene , 1989, Antimicrobial Agents and Chemotherapy.
[186] P. Courvalin,et al. Dispersal in Campylobacter spp. of aphA-3, a kanamycin resistance determinant from gram-positive cocci , 1988, Antimicrobial Agents and Chemotherapy.
[187] P. Trieu-Cuot,et al. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. , 1983, Gene.
[188] F. Tenover,et al. Detection of two different kanamycin resistance genes in naturally occurring isolates of Campylobacter jejuni and Campylobacter coli , 1988, Antimicrobial Agents and Chemotherapy.
[189] T. Ida,et al. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus. , 1994, Drugs under experimental and clinical research.
[190] N. Barg. Construction of a probe for the aminoglycoside 3-V-acetyltransferase gene and detection of the gene among endemic clinical isolates , 1988, Antimicrobial Agents and Chemotherapy.
[191] C. Schaffner,et al. Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa , 1995, Antimicrobial agents and chemotherapy.
[192] D. Northrop,et al. Alternative substrate and inhibition kinetics of aminoglycoside nucleotidyltransferase 2''-I in support of a Theorell-Chance kinetic mechanism. , 1988, Biochemistry.
[193] J. Puglisi,et al. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. , 1998, Journal of molecular biology.
[194] J. Prescott,et al. The use of liposomally-entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis. , 1988, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[195] L. Brakier-Gingras,et al. A mutation in the 530 loop of Escherichia coli 16S ribosomal RNA causes resistance to streptomycin. , 1988, Nucleic acids research.
[196] J. Verhoef,et al. Prevalence of Aminoglycoside Resistance in 20 European University Hospitals Participating in the European SENTRY Antimicrobial Surveillance Programme , 1999, European Journal of Clinical Microbiology and Infectious Diseases.
[197] P. Nordmann,et al. Molecular Characterization of OXA-20, a Novel Class D β-Lactamase, and Its Integron from Pseudomonas aeruginosa , 1998, Antimicrobial Agents and Chemotherapy.
[198] A. Jones,et al. Nucleotide sequence analysis of a transposon (Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other gram-negative bacteria , 1993, Journal of bacteriology.
[199] J. Hopfield. Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[200] J. Blanchard,et al. Overexpression and Mechanistic Analysis of Chromosomally Encoded Aminoglycoside 2′-N-Acetyltransferase (AAC(2′)-Ic) fromMycobacterium tuberculosis * , 2001, The Journal of Biological Chemistry.
[201] R. Hall,et al. Nucleotide sequence of the AAD(2'') aminoglycoside adenylyltransferase determinant aadB. Evolutionary relationship of this region with those surrounding aadA in R538-1 and dhfrII in R388. , 1986, Nucleic acids research.
[202] P. Rather,et al. Nucleotide sequence analysis and DNA hybridization studies of the ant(4')-IIa gene from Pseudomonas aeruginosa , 1993, Antimicrobial Agents and Chemotherapy.
[203] E. Begg,et al. Comparison of gentamicin dosing regimens using an in-vitro model. , 1992, The Journal of antimicrobial chemotherapy.
[204] R. Hancock. Alterations in outer membrane permeability. , 1984, Annual review of microbiology.
[205] F. Szoka,et al. Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. , 1987, Investigative ophthalmology & visual science.
[206] B. Gicquel,et al. Aminoglycoside 2′‐N‐acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2 ′)‐Ic gene from Mycobacterium tuberculosis and the aac(2 ′)‐Id gene from Mycobacterium smegmatis , 1997, Molecular microbiology.
[207] P. Courvalin,et al. Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp , 1990, Antimicrobial Agents and Chemotherapy.
[208] R. Wallace,,et al. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. , 1998, The Journal of infectious diseases.
[209] H. Segal,et al. Identification and characterization of an aadB gene cassette at a secondary site in a plasmid from Acinetobacter. , 1997, FEMS microbiology letters.
[210] Hoshiko Shigeru,et al. Nucleotide sequence of the ribostamycin phosphotransferase gene and of its control region in Streptomyces ribosidificus. , 1988 .
[211] L. Bryan,et al. Effects of Membrane-Energy Mutations and Cations on Streptomycin and Gentamicin Accumulation by Bacteria: a Model for Entry of Streptomycin and Gentamicin in Susceptible and Resistant Bacteria , 1977, Antimicrobial Agents and Chemotherapy.
[212] M. Sande,et al. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. , 1976, The Journal of laboratory and clinical medicine.
[213] D. Krogstad,et al. Resistance to Six Aminoglycosidic Aminocyclitol Antibiotics Among Enterococci: Prevalence, Evolution, and Relationship to Synergism with Penicillin , 1977, Antimicrobial Agents and Chemotherapy.
[214] V. Ramakrishnan,et al. The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit , 2000, Cell.
[215] C. Sigmund,et al. Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli. , 1984, Nucleic acids research.
[216] R. Bulger. In-vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. , 1967, Lancet.
[217] S. Lory,et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.
[218] B. Purnelle,et al. Sequence of the Bacillus subtilis genome region in the vicinity of the lev operon reveals two new extracytoplasmic function RNA polymerase sigma factors SigV and SigZ. , 1997, Microbiology.
[219] K. Shaw,et al. Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa , 1989, Antimicrobial Agents and Chemotherapy.
[220] L. de wit,et al. Characterization of the 6'-N-aminoglycoside acetyltransferase gene aac(6')-Im [corrected] associated with a sulI-type integron , 1997, Antimicrobial agents and chemotherapy.
[221] L. Young,et al. GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever , 1997 .
[222] H. Noller,et al. Ribosomes and translation. , 1997, Annual review of biochemistry.
[223] K. Keddy,et al. Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. , 2001, The Journal of antimicrobial chemotherapy.
[224] R. Lenk,et al. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. , 1985, The Journal of infectious diseases.
[225] W. Craig,et al. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli. , 1991, The Journal of antimicrobial chemotherapy.
[226] L. Kotra,et al. Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3'-phosphotransferases. , 2000, The Journal of organic chemistry.
[227] J. Puglisi,et al. Sequence-specific recognition of the major groove of RNA by deoxystreptamine. , 2002, Biochemistry.
[228] S. Mobashery,et al. Resolving the Antibiotic Paradox , 1998, Advances in Experimental Medicine and Biology.
[229] P. Nordmann,et al. Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa. , 1999, Biochimica et biophysica acta.
[230] D. Nicolau,et al. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. , 1997, The Journal of antimicrobial chemotherapy.
[231] P. Miller,et al. Bacterial uptake of aminoglycoside antibiotics. , 1987, Microbiological reviews.
[232] M. Sande,et al. Penicillin-netilmicin synergism against Streptococcus faecalis , 1978, Antimicrobial Agents and Chemotherapy.
[233] T. Ida,et al. Antagonism between Aminoglycosides and β-Lactams in a Methicillin-Resistant Staphylococcus aureus Isolate Involves Induction of an Aminoglycoside-Modifying Enzyme , 2002, Antimicrobial Agents and Chemotherapy.
[234] D. Sandvang. Novel Streptomycin and Spectinomycin Resistance Gene as a Gene Cassette within a Class 1 Integron Isolated from Escherichia coli , 2000, Antimicrobial Agents and Chemotherapy.
[235] G. Eliopoulos,et al. Antibiotic combinations: should they be tested? , 1988, Clinical Microbiology Reviews.
[236] Jill K Thompson,et al. Methylation of 16S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin-producer, Micromonospora purpurea , 2004, Molecular and General Genetics MGG.
[237] T. Aoki,et al. The Transposon‐Like Structure of IS26‐Tetracycllne, and Kanamycin Resistance Determinant Derived from Transferable R Plasmid of Fish Pathogen, Pasteurella piscicida , 1994, Microbiology and immunology.
[238] G. Wright,et al. Overexpression and characterization of the chromosomal aminoglycoside 6'-N-acetyltransferase from Enterococcus faecium , 1997, Antimicrobial agents and chemotherapy.
[239] T. Eickhoff,et al. Effects of Ampicillin-Amikacin and Ampicillin-Rifampin on Enterococci , 1976, Antimicrobial Agents and Chemotherapy.
[240] J. Puglisi,et al. Structure of the A Site of Escherichia coli 16S Ribosomal RNA Complexed with an Aminoglycoside Antibiotic , 1996, Science.
[241] P. Rather,et al. Cloning and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens , 1992, Antimicrobial Agents and Chemotherapy.
[242] J. Frean,et al. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus , 1996, Antimicrobial agents and chemotherapy.
[243] D. Northrop,et al. Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2''-I. , 1988, Biochemistry.
[244] S. Tsai,et al. A novel gentamicin resistance gene in Enterococcus , 1997, Antimicrobial agents and chemotherapy.
[245] D. Hollis,et al. Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth , 1985, Journal of clinical microbiology.
[246] P. H. Roy,et al. Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria , 1992, Journal of bacteriology.
[247] C. Torres,et al. Bifunctional Enzyme 6′-N-Aminoglycoside Acetyltransferase-2"-O- Aminoglycoside Phosphotransferase in Lactobacillus and Pediococcus Isolates of Animal Origin , 2001, Journal of Clinical Microbiology.
[248] R. Hütter,et al. Characterisation of the hydroxystreptomycin phosphotransferase gene (sph) of Streptomyces glaucescens: Nucleotide sequence and promoter analysis , 1987, Molecular and General Genetics MGG.
[249] J. Verhoef,et al. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. , 1999, The Journal of antimicrobial chemotherapy.
[250] A. Forsgren,et al. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984. , 1986, Scandinavian journal of infectious diseases.
[251] M. Ehrenberg,et al. Dissociation rate of cognate peptidyl-tRNA from the A-site of hyper-accurate and error-prone ribosomes. , 1994, European journal of biochemistry.
[252] W. Epstein,et al. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics , 1981, Antimicrobial Agents and Chemotherapy.
[253] C. Vonrhein,et al. Structure of the 30S ribosomal subunit , 2000, Nature.
[254] P. H. Roy,et al. Presence of a Group II Intron in a Multiresistant Serratia marcescens Strain That Harbors Three Integrons and a Novel Gene Fusion , 2002, Antimicrobial Agents and Chemotherapy.
[255] A E Dahlberg,et al. A conformational switch in Escherichia coli 16S ribosomal RNA during decoding of messenger RNA. , 1997, Science.
[256] J. Davies,et al. Plasmid-determined resistance to antimicrobial agents. , 1978, Annual review of microbiology.
[257] Y. Zhang,et al. Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model. , 1993, Ophthalmology (Rochester, Minn.).
[258] S. Ünal,et al. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[259] W. Fitch,et al. Evolution of antibiotic resistance genes: the DNA sequence of a kanamycin resistance gene from Staphylococcus aureus. , 1983, Molecular biology and evolution.
[260] A. Ebert,et al. Gene cluster for streptomycin biosynthesis in Streptomyces griseus: nucleotide sequence of three genes and analysis of transcriptional activity. , 1987, Nucleic acids research.
[261] E. Scherzinger,et al. Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010. , 1989, Gene.
[262] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[263] D. Shanson. New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. , 1998, The Journal of antimicrobial chemotherapy.
[264] T. Tadakuma,et al. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes , 1985, Antimicrobial Agents and Chemotherapy.
[265] N. Kobayashi,et al. Distribution of aminoglycoside resistance genes in recent clinical isolates of Enterococcus faecalis, Enterococcus faecium and Enterococcus avium , 2001, Epidemiology and Infection.
[266] D. Reeves,et al. AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin. , 1987, The Journal of antimicrobial chemotherapy.
[267] Amita,et al. Occurrence of Antibiotic Resistance Gene Cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in Class I Integrons in Non-O1, Non-O139 Vibrio cholerae Strains in India , 2002, Antimicrobial Agents and Chemotherapy.
[268] R. Owens,et al. In vitro synergistic activities of tobramycin and selected beta-lactams against 75 gram-negative clinical isolates , 1997, Antimicrobial agents and chemotherapy.
[269] P. Courvalin,et al. Detection of apramycin resistant Enterobacteriaceae in hospital isolates. , 1989, FEMS microbiology letters.
[270] R. Sutherland,et al. Synergy Between Ticarcillin and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae In Vitro and In Vivo , 1977, Antimicrobial Agents and Chemotherapy.
[271] A. Dashti,et al. Detection of genes encoding aminoglycoside-modifying enzymes in staphylococci by polymerase chain reaction and dot blot hybridization. , 2000, International journal of antimicrobial agents.
[272] M. Matsumura,et al. Enzymatic and nucleotide sequence studies of a kanamycin-inactivating enzyme encoded by a plasmid from thermophilic bacilli in comparison with that encoded by plasmid pUB110 , 1984, Journal of bacteriology.
[273] B. Khoobehi,et al. Intravitreal liposome-encapsulated drugs: A preliminary human report , 2004, International Ophthalmology.
[274] T. Calandra,et al. Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .
[275] P. O'Hara,et al. Nucleotide sequence of a novel kanamycin resistance gene, aphA-7, from Campylobacter jejuni and comparison to other kanamycin phosphotransferase genes. , 1989, Plasmid.
[276] R. Moss. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. , 2002, Chest.
[277] A. Goffeau,et al. Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[278] M. Ploy,et al. Molecular Characterization of Integrons inAcinetobacter baumannii: Description of a Hybrid Class 2 Integron , 2000, Antimicrobial Agents and Chemotherapy.
[279] Lakshmi P Kotra,et al. Design of novel antibiotics that bind to the ribosomal acyltransfer site. , 2002, Journal of the American Chemical Society.
[280] M. Zervos,et al. Efficacy of Ampicillin plus Arbekacin in Experimental Rabbit Endocarditis Caused by an Enterococcus faecalis Strain with High-Level Gentamicin Resistance , 2000, Antimicrobial Agents and Chemotherapy.
[281] J. Ninio. Kinetic amplification of enzyme discrimination. , 1975, Biochimie.
[282] J. Davies,et al. Enzymatic Modification of Aminoglycoside Antibiotics: a New 3-N-Acetylating Enzyme from a Pseudomonas aeruginosa Isolate , 1976, Antimicrobial Agents and Chemotherapy.
[283] G. Sundin,et al. Dissemination of the strA‐strB streptomycin‐resistance genes among commensal and pathogenic bacteria from humans, animals, and plants , 1996, Molecular ecology.
[284] W. Witte,et al. Aminoglycoside-Streptothricin Resistance Gene Cluster aadE–sat4–aphA-3 Disseminated among Multiresistant Isolates of Enterococcus faecium , 2001, Antimicrobial Agents and Chemotherapy.
[285] P. Gangadharam,et al. Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. , 1991, The Journal of antimicrobial chemotherapy.
[286] J. Klastersky,et al. Bacteriological and clinical activity of the ampicillin/gentamicin and cephalothin/gentamicin combinations , 1971, The American journal of the medical sciences.
[287] P. Courvalin,et al. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase , 1988, Antimicrobial Agents and Chemotherapy.
[288] R. Ramphal. 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever , 1998 .
[289] J. Altenbuchner,et al. A spectinomyciin resistance determinant from the spectinomycin producerStreptomyces flavopersicus , 1997 .
[290] B. Gicquel,et al. Characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase gene from Mycobacterium fortuitum , 1996, Antimicrobial agents and chemotherapy.
[291] P. H. Roy,et al. Characterization of the 6′-N-Aminoglycoside Acetyltransferase Geneaac(6′)-Iq from the Integron of a Natural Multiresistance Plasmid , 1998, Antimicrobial Agents and Chemotherapy.
[292] G. Eliopoulos,et al. Ribosomal resistance of clinical enterococcal to streptomycin isolates , 1984, Antimicrobial Agents and Chemotherapy.
[293] J. Musser,et al. Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.
[294] D. Vapnek,et al. Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenyltransferase , 1985 .
[295] V. Ramakrishnan,et al. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics , 2000, Nature.
[296] L. Couch. Treatment With tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa. , 2001, Chest.
[297] R. Moore,et al. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. , 1987, The Journal of infectious diseases.
[298] L. Kotra,et al. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. , 2002, Chemistry & biology.
[299] M. Mulvey,et al. Characterization of Variant Salmonella Genomic Island 1 Multidrug Resistance Regions from Serovars Typhimurium DT104 and Agona , 2002, Antimicrobial Agents and Chemotherapy.
[300] A. Dalsgaard,et al. Distribution and Content of Class 1 Integrons in Different Vibrio cholerae O-Serotype Strains Isolated in Thailand , 2000, Antimicrobial Agents and Chemotherapy.
[301] K. Ubukata,et al. Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis , 1984, Antimicrobial Agents and Chemotherapy.
[302] P. Rather,et al. Contribution of gentamicin 2'-N-acetyltransferase to the O acetylation of peptidoglycan in Providencia stuartii , 1995, Journal of bacteriology.
[303] D. Raoult,et al. Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria , 2001, Antimicrobial Agents and Chemotherapy.
[304] V. Ramakrishnan,et al. Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA. , 2002, Journal of molecular biology.
[305] C. Carlier,et al. Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci , 1990, Antimicrobial Agents and Chemotherapy.
[306] W. Craig,et al. Postantibiotic suppression of bacterial growth. , 1981, Reviews of infectious diseases.
[307] P. Nordmann,et al. Characterization of Class 1 Integrons from Pseudomonas aeruginosa That Contain the blaVIM-2Carbapenem-Hydrolyzing β-Lactamase Gene and of Two Novel Aminoglycoside Resistance Gene Cassettes , 2001, Antimicrobial Agents and Chemotherapy.
[308] J. Davies,et al. Enzymatic Modification of Aminoglycoside Antibiotics: a New 6′-N-Acetylating Enzyme from a Pseudomonas aeruginosa Isolate , 1976, Antimicrobial Agents and Chemotherapy.
[309] J. Content,et al. Nomenclature of Genes Encoding Aminoglycoside-Modifying Enzymes , 1998, Antimicrobial Agents and Chemotherapy.
[310] C. Kurland,et al. Streptomycin preferentially perturbs ribosomal proofreading , 2004, Molecular and General Genetics MGG.
[311] G. Sundin,et al. Ecological and genetic analysis of copper and streptomycin resistance in Pseudomonas syringae pv. syringae , 1993, Applied and environmental microbiology.
[312] P. Rather,et al. Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins , 1992, Journal of bacteriology.
[313] J. Vliegenthart,et al. Nucleotide sequence of the aacC3 gene, a gentamicin resistance determinant encoding aminoglycoside-(3)-N-acetyltransferase III expressed in Pseudomonas aeruginosa but not in Escherichia coli , 1991, Antimicrobial Agents and Chemotherapy.
[314] J. Altenbuchner,et al. A spectinomycin resistance determinant from the spectinomycin producer Streptomyces flavopersicus. , 1997, Microbiology.
[315] S. Waksman,et al. Effect of Streptomycin and Other Antibiotic Substances upon Mycobacterium tuberculosis and Related Organisms.∗,† , 1944 .
[316] P. Courvalin,et al. Aminoglycoside-modifying enzymes of Staphylococcus aureus; expression in Escherichia coli. , 1980, Gene.
[317] Nucleotide sequence of the chromosomal gene coding for the aminoglycoside 6-adenylyltransferase from Bacillus subtilis Marburg 168. , 1989 .
[318] C. Baxter,et al. Liposome delivery of aminoglycosides in burn wounds. , 1992, Surgery, gynecology & obstetrics.
[319] M. Ploy,et al. Characterization of the Chromosomalaac(6′)-Iz Gene of Stenotrophomonas maltophilia , 1999, Antimicrobial Agents and Chemotherapy.
[320] C. Carlier,et al. Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci , 1990, Antimicrobial Agents and Chemotherapy.
[321] P. Rather,et al. Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii , 1993, Journal of bacteriology.
[322] P. Courvalin,et al. Characterization of the aac(6')-Ik gene of Acinetobacter sp. 6. , 1994, FEMS microbiology letters.
[323] P. Rather,et al. Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens , 1992, Antimicrobial Agents and Chemotherapy.
[324] F. Schluenzen,et al. Structure of Functionally Activated Small Ribosomal Subunit , 2000 .
[325] M. Zervos,et al. A New High-Level Gentamicin Resistance Gene,aph(2")-Id, in Enterococcus spp , 1998, Antimicrobial Agents and Chemotherapy.
[326] J. H. Crosa,et al. Genetic organization of antibiotic resistance genes (aac(6')-Ib, aadA, and oxa9) in the multiresistance transposon Tn1331. , 1993, Plasmid.
[327] G. Wright,et al. Kinetic Mechanism of Aminoglycoside Phosphotransferase Type IIIa , 1995, The Journal of Biological Chemistry.
[328] F. Kayser,et al. Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosa , 1996, Antimicrobial agents and chemotherapy.
[329] C. Baxter,et al. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics. , 1994, Surgery.
[330] Y. Aoki. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. , 1994, The Japanese journal of antibiotics.
[331] T. Steitz,et al. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. , 2000, Science.
[332] G. Sundin,et al. Expression of the strA-strB streptomycin resistance genes in Pseudomonas syringae and Xanthomonas campestris and characterization of IS6100 in X. campestris , 1995, Applied and environmental microbiology.
[333] T. Ida,et al. Identification of Aminoglycoside-Modifying Enzymes by Susceptibility Testing: Epidemiology of Methicillin-Resistant Staphylococcus aureus in Japan , 2001, Journal of Clinical Microbiology.
[334] Frank Schluenzen,et al. High Resolution Structure of the Large Ribosomal Subunit from a Mesophilic Eubacterium , 2001, Cell.